Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-02 Sale | 2026-02-02 6:30 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 32,410 | $185.6 | $6,015,296 | 7,351,729 (Indirect Direct) | View |
| 2026-01-05 Sale | 2026-01-07 7:00 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 139,414 | $171.3 | $23,881,618 | 7,540,931 (Indirect Direct) | View |
| 2025-12-02 Sale | 2025-12-04 7:39 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 79,973 | $145.66 | $11,648,582 | 7,908,480 (Indirect Direct) | View |
| 2025-11-03 Sale | 2025-11-05 7:01 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 163,939 | $133.07 | $21,815,669 | 8,201,129 (Indirect Direct) | View |
| 2025-10-06 Sale | 2025-10-08 9:08 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 45,384 | $119.38 | $5,418,060 | 8,637,875 (Indirect Direct) | View |
| 2025-09-12 Sale | 2025-09-16 7:36 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 62,880 | $117.08 | $7,361,891 | 8,789,781 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-26 Option Award | 2026-02-27 7:10 pm | N/A 2036-02-26 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 54,623 | $0 | 54,623 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-02 6:30 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 32,410 | $0 | 7,351,729 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-02 6:30 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 32,410 | $8.02 | 7,351,729 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-07 7:00 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 139,414 | $0 | 7,540,931 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-07 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 139,414 | $8.02 | 7,540,931 (Direct) | View |
| 2025-12-02 Exercise | 2025-12-04 7:39 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 79,973 | $0 | 7,908,480 (Direct) | View |
| 2025-12-02 Exercise | 2025-12-04 7:39 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 79,973 | $8.02 | 7,908,480 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-05 7:01 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 163,939 | $0 | 8,201,129 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-05 7:01 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 163,939 | $8.02 | 8,201,129 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:08 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 45,384 | $0 | 8,637,875 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 45,384 | $8.02 | 8,637,875 (Direct) | View |
| 2025-09-12 Exercise | 2025-09-16 7:36 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 62,880 | $0 | 8,789,781 (Direct) | View |
| 2025-09-12 Exercise | 2025-09-16 7:36 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 62,880 | $8.02 | 8,789,781 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 7:51 pm | N/A 2035-02-20 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 86,105 | $0 | 86,105 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:20 pm | N/A 2034-02-26 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 135,078 | $0 | 135,078 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:16 pm | N/A 2033-03-01 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 172,432 | $0 | 172,432 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:04 pm | N/A 2032-03-03 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 320,516 | $0 | 320,516 (Direct) | View |